Earnings Release • May 19, 2017
Earnings Release
Open in ViewerOpens in native device viewer
Annual Report 2016 – Short Version
15.6% EBITDA
OPERATING CHF 55.6M
AEVIS VICTORIA SA invests in services to people, healthcare, hospitality, life sciences and lifestyle. AEVIS VICTORIA′s main shareholdings are Swiss Medical Network SA, the second largest group of private hospitals in Switzerland, Victoria-Jungfrau Collection AG, a luxury hotel group managing five luxury hotels in Switzerland, a healthcare and hospitality real estate division, Medgate, the leading telemedicine provider in Switzerland, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW).
| FY2016 (pro-forma |
|||
|---|---|---|---|
| (In thousands of CHF | incl. 12 | FY2015 | |
| unless otherwise stated) | FY2016 | months GBH) | Restated |
| Total revenue | 592′595 | 664′870 | 576′058 |
| Net revenue | 517′106 | 583′055 | 508′607 |
| EBITDAR* | 87′141 | 101′432 | 78′452 |
| EBITDAR margin | 16.9% | 17.4% | 15.4% |
| EBITDA | 74′605 | 86′658 | 64′513 |
| EBITDA margin | 14.4% | 14.9% | 12.7% |
| EBIT | 31′448 | 37′928 | 23′862 |
| EBIT margin | 6.1% | 6.5% | 4.7% |
| Profit for the period | 2′692 | 5′791 | 3′747 |
| Number of FTE at year-end | 2′856 | 2′587 | |
| Market price per share at 31.12. in CHF | 64.00 | 40.95 | |
| Number of outstanding shares | 15′016′768 | 15′010′091 | |
| Market capitalisation | 961′073 | 614′663 |
*Earnings before interest, taxes, depreciation, amortisation and rental expenses
| Share and bond information | 4 |
|---|---|
| Letter to the Shareholders | 8 |
| Swiss Medical Network | 14 |
| Victoria-Jungfrau Collection | 22 |
| Hospital and Hospitality Real Estate | 28 |
| Other participations | 34 |
| Corporate Governance | 36 |
| Financial Statements | 40 |
The complete and legally binding annual report is available on www.aevis.com
Share Register Computershare Schweiz AG Tel. +41 62 205 77 00 [email protected]
| No. of registered shares outstanding | 15′016′768 | 15′010′091 |
|---|---|---|
| No. of treasury shares | 115′639 | 25′116 |
| Nominal value per registered shares (in CHF) | 5 | 5 |
| No. of registered shares issued | 15′132′407 | 15′035′207 |
| Share capital (in CHF) | 75′662′035 | 75′176′035 |
| 31.12.2016 | 31.12.2015 |
| 31.12.2016 | 31.12.2015 | |
|---|---|---|
| EBITDA per share* (in CHF) | 4.99 | 4.41 |
| High (in CHF) | 64.40 | 47.10 |
| Low (in CHF) | 37.50 | 39.50 |
| End price (in CHF) | 64.00 | 40.95 |
| Average volume per day | 1′692 | 1′517 |
| Market capitalisation (in CHF) | 961′073′152 | 614′663′226 |
*EBITDA divided by the weighted average number of shares outstanding, excluding treasury shares.
The registered shares of AEVIS VICTORIA SA are traded on the Swiss Reporting Standard of SIX Swiss Exchange and are part of the Swiss Performance Index SPI, the SXI Life Sciences Index (SLIFE) and the SXI Bio+Medtech Index (SBIOM).
| Valor symbol: | AEVS | Bloomberg: | AEVS SW Equity |
|---|---|---|---|
| Valor no.: | 1248819 | Reuters: | AEVS.S. |
| ISIN: | CH0012488190 |
Media & Investor Relations c/o Dynamics Group AG Philippe Blangey Tel. +41 43 268 32 32 [email protected]
The following shareholders held more than 3% on 31 December 2016:
| Total shareholders (31 December 2016) | 1′640 |
|---|---|
| of the State of Kuwait | |
| Kuwait Investment Office as agent for the Government | 3.52% |
| Services and Investments SA | |
| Group Hubert/Reybier/M.R.S.I. Medical Research, | 77.49% |
| 13 June 2017 | Ordinary general shareholders meeting for the year 2016 |
|---|---|
| 15 September 2017 | Publication of the 2017 Half-Year Results |
| November 2017 | Publication of 3Q 2017 Revenue |
| March 2018 | Publication of 2017 Revenue |
| 29 March 2018 | Publication of the 2017 Annual Results |
In 2016, all three major subsidiaries of AEVIS VICTORIA SA (AEVIS VICTORIA) realised operational and financial progress. Organic growth combined with targeted acquisitions and internal optimisations contributed to increased revenues and improved profit margins. Swiss Medical Network finalised the integration of Clinique Générale-Beaulieu in Geneva, Victoria-Jungfrau Collection improved revenues in spite of the negative trend in the luxury hotel industry, and the value of the property portfolio grew to more than one billion Swiss Francs. The corporate structure is designed to absorb the acquisitions of 2016 and allows the continuation of the successful buy-and-build-strategy at the same time.
Total revenues grew by 2.9% to CHF 592.6 million (2015: CHF 576.1 million) and net revenues (medical fees excluded) amounted to CHF 517.1 million (2015: CHF 508.6 million). Substantial efficiency gains and the exploitation of synergies contributed to a higher operating profit. The EBITDAR in the two main segments surpassed the 20% level in the year under review. On the Group level, an EBITDAR of CHF 87.1 million, up by 11.1% from the previous year (2015: CHF 78.5 million) resulted, corresponding to a solid EBITDAR margin of 16.9%. EBITDA reached CHF 74.6 million or 14.4% of turnover and the EBIT increased by 31.8% from CHF 23.9 million to CHF 31.4 million. The operating cash flow surged significantly by 52.0% to CHF 55.6 million in the year under review. The profit for the period amounts to CHF 2.7 million. On a pro-forma basis, consolidating Générale-Beaulieu for 12 months, the increases in sales, profit margins and net profit was even higher.
The Board of Directors will propose to the Annual General Meeting a distribution from capital contribution reserves of CHF 0.55 per share, in line with its long-term distribution policy.
Swiss Medical Network performed well in 2016. An increased number of patients offset lower DRG and TARMED rates in Switzerland and resulted in a record turnover of CHF 521.0 million, up from CHF 482.8 million in the previous year. Operational improvements and synergies contributed to an EBITDAR of CHF 91.9 million, 29.8% more than a year ago. This solid operational result corresponds to an EBITDAR margin of 20.6% (2015: 17.0%). A full year consolidation of Clinique Générale-Beaulieu in Swiss Medical Network would have generated a pro forma revenue of CHF 591.0 million and a pro forma EBITDAR of 104.6 million.
Distribution from capital contribution reserves of CHF 0.55 per share proposed
The network′s growth continued with the successful integration of Clinique Générale-Beaulieu in late 2016. The Geneva-based multidisciplinary hospital is specialised in orthopaedics, general surgery, urology, gynaecology and obstetrics. Clinique Générale-Beaulieu has 477 employees and 571 admitting physicians, and achieved a turnover of CHF 83.4 million and an EBITDAR of CHF 15.7 million in 2016. The network now consists of 15 hospitals, one affiliated hospital and one clinic, with 988 available beds, 1′782 admitting physicians and 2′948 employees.
Swiss Medical Network made a crucial contribution to contain healthcare costs in Switzerland in reducing its base rates. A common flat rate payment system for all listed hospitals at the rate of CHF 9′050 per case was introduced in March 2016, and it was further reduced on 1 January 2017 to CHF 8′930. These rates are substantially lower than the insurers′ benchmark (HSK and Tarifsuisse, both around CHF 9′500) and around 10% below those of the public hospitals (above CHF 10′000).
The luxury hotels of Victoria-Jungfrau Collection achieved turnover gains despite a drop in tourism activities in Switzerland. The net revenue grew from CHF 58.9 million in 2015 to CHF 60.7 million in 2016. Palace Lucerne is operated by the Group but no longer consolidated, as a new management contract structure was put in place on 1 January 2016. The number of overnight stays remained constant at around 169′000 and the average room rate increased from CHF 366 a year ago to CHF 372 in the period under review (three fully consolidated hotels). Further efficiency gains and cost savings contributed to the profitability and the EBITDAR margin reached 20.1%. On 1 December 2016, Victoria-Jungfrau Collection acquired the operations of the Hotel Crans Ambassador, a luxury sport resort in Crans-Montana (canton of Valais), and thereby enlarged the portfolio to a fifth establishment. The hotel Crans Ambassador has 56 rooms and employs 60 people.
Rental income in the real estate segment, composed of healthcare- and hospitality-related real estate, amounted to CHF 51.2 (2015: CHF 36.4 million) and EBITDAR surged to CHF 42.4 (2015: CHF 32.5 million), which mostly corresponds to intercompany payments with AEVIS VICTORIA′s hospital and hospitality segments. With the purchase of an office building in Echandens and the acquisition of three buildings in Geneva in connection with the integration of Générale Beaulieu, the property portfolio grew to 44 properties on 17 sites and represents a total rentable surface of 193′880 sqm with a market value of CHF 1′148.3 million.
An extensive refurbishment program was completed at Clinique de Valère in Sion, and further targeted investments were made in Clinique Générale in Fribourg, Clinique Montchoisi in Lausanne, Clinica Ars Medica in Gravesano, Privatklinik Lindberg in Winterthur and Privatklinik Bethanien in Zurich. At Privatklinik Villa im Park in Rothrist, construction of a new building will start in spring 2017 and rental space of 2′300 sqm with 30 new rooms will be available upon completion.
In January 2016 the acquisition of 40% of Medgate Group, the leading provider of telemedical services in Switzerland, was completed. Since July 2016, AEVIS VICTORIA holds a participation in the listed company LifeWatch AG, a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market. After the purchase of a 4.6% stake within the context of LifeWatch′s rights offering, the shareholding was further increased to 11.99% later in 2016.
AEVIS VICTORIA launched a public takeover bid for all publicly held registered shares of LifeWatch in early 2017, with the offer period ranging from 7 March 2017 to 10 April 2017. LifeWatch shareholders can opt for an exchange offer or a cash alternative. For each registered share of LifeWatch, 0.1818 registered shares of AEVIS VICTORIA are offered. Alternatively, AEVIS VICTORIA offers CHF 10.00 in cash per registered share of LifeWatch.
AEVIS VICTORIA has a proven track record in transforming and growing companies in the health sector
In the event of a completion of its public takeover bid, AEVIS VICTORIA intends to significantly contribute to pursuing LifeWatch′s growth strategy and is convinced that LifeWatch would benefit from the support of a reference shareholder with a strong presence in the healthcare sector. AEVIS VICTORIA would be able to provide a long-term vision and the necessary financial means to develop the business strategy of LifeWatch. AEVIS VICTORIA has a proven track record in transforming and growing companies in the health sector, and LifeWatch would also benefit from this broad experience.
On 9 March 2017, a committee of the Board of Directors of LifeWatch has recommended the rejection of AEVIS VICTORIA′s offer. The committee considers AEVIS VICTORIA′s offer not to be in the best interest of LifeWatch and its shareholders as they believe that it does not reflect the real value of the company. The committee has solicited alternative offers and mandated an investment bank to help them in this process. AEVIS VICTORIA is concerned about how the process is being handled by the committee and management of LifeWatch. AEVIS VICTORIA will wait and see how the transaction evolves and the take the necessary measures in due course to protect the best interest of its shareholders.
AEVIS VICTORIA invests in various other businesses along the value chain of its main pillars of activity. The rescue entity based in Geneva was rebranded as Swiss Ambulance Rescue in late September 2016. NESCENS preventive medical checkup centres are now operative in Genolier, Lausanne, Lugano and soon in Zurich, while NESCENS better-aging medspa programs are available in Interlaken and Geneva. For the first time, the anti-aging cosmetics of NESCENS are also sold in a dedicated e-shop targeting international buyers. In addition, Nescens Clinique de Genolier is offering a unique combination of both hotel services and medical care.
The Board of Directors is authorised to increase the share capital by a nominal value of maximum CHF 35.5 million through the issuance of 7.1 million new shares until 28 June 2017, with the objective to finance potential acquisitions. This would also include the potential takeover of LifeWatch.
AEVIS VICTORIA was once again active on the capital markets and benefited from favourable refinancing conditions. In May 2016 it successfully issued a new 5-year CHF 150 million straight bond with a coupon of 2.5%. The net proceeds of the bond were partially used to refinance the CHF 80 million, 4.25% bond AEV12 that matured on 3 August 2016. Another 6-year CHF 130 million straight bond with a coupon of 2.0% was issued on 20 September 2016. It was subsequently increased to CHF 145 million due to high investor demand.
As the free float soared above the 20% threshold following the full integration of Victoria-Jungfrau Collection, the nominal shares of AEVIS VICTORIA were included in the Swiss Performance Index (SPI) in late July 2016. They are also included in the SXI Life Sciences Index (SLIFE) and SXI Bio+Medtech Index (SBIOM) since 19 September 2016.
For the entire business year 2017, AEVIS VICTORIA SA expects to realise a total revenue of more than CHF 700 million based on an unchanged portfolio consolidated over a 12-month period. AEVIS VICTORIA expects to realise an EBITDA of more than CHF 100 million, without acquisitions.
We would like to conclude by thanking our customers and partners for the gratifying development of our collaboration, our shareholders for their confidence and all our employees and physicians for their great work and commitment.
Fribourg, 24 March 2017
Christian Wenger Antoine Hubert Chairman of the Board Delegate of the Board
Swiss Medical Network, founded in 2002, is one of Switzerland′s leading private hospitals groups. Its hospitals, which are located in all three of the country′s main language regions, provide first-class hospital treatment, care and assistance to patients from Switzerland and abroad.
All Swiss Medical Network hospitals are renowned for the quality of their services, their excellent medical facilities, their top-notch hotellerie and their pleasant ambience. With their state-of-the-art medical technology and their comprehensive specialist expertise, the hospitals of Swiss Medical Network offer reliable medical care of the very highest calibre which puts the patient′s comfort and well-being firmly centre stage.
Swiss Medical Network continues to develop and expand its Swiss-wide network by acquiring and restructuring further hospital facilities. The network currently extends to 16 private institutions and one affiliated hospital in Switzerland, which count 1′782 doctors and employ 2′948 other personnel. Swiss Medical Network is also linked with Klinik Pyramide am See AG, which operates a hospital in the canton of Zürich.
The medical competences of the Swiss Medical Network hospitals are recognised beyond the Swiss borders with, for example, the first Breast Centre of a group of private hospitals to be certified in French speaking Switzerland, a pain clinic in Basel, expertise and high-tech oncology equipment and recognised maternity wards.
Swiss Medical Network SA is a fully-owned subsidiary of AEVIS VICTORIA.
www.swissmedical.net
Swiss Medical Network reached a turnover of CHF 521.0 million, up from CHF 482.8 million in the previous year, representing growth of 7.9%. Organic growth excluding acquisitions amounted to 4.3%. The exploitation of synergies and efficiency gains contributed to the improved EBITDAR of CHF 91.9 million, corresponding to an EBITDAR margin of 20.6%. The network′s growth path continued with the acquisition and integration of Clinique Générale-Beaulieu in Geneva in the last quarter of 2016. Swiss Medical Network now consists of 15 hospitals, one affiliated hospital and one clinic in 10 cantons.
An overall increase in the number of patients resulted in a record turnover, despite lower DRG and TARMED rates for the domestic activities of Swiss Medical Network. Medical tourism recovered compared to the previous year and surged by nearly 10%. In total, turnover including the residence Nescens Clinique de Genolier increased by 7.9% from CHF 482.8 million to CHF 521.0 million. Net revenues, excluding medical fees, amounted to CHF 446.2 million (2015: CHF 416.1 million).
Organic growth without acquisitions of 4.3%
All hospitals but Privatklinik Lindberg are in the optimisation phase of their business cycle and thereby contributed to the positive earnings. Further operational improvements combined with synergy gains led to an improved EBITDAR of CHF 91.9 million (2015: CHF 70.9 million) corresponding to a solid EBITDAR margin of 20.6% (2015: 17.0%). Once again, the actions initiated and implemented in the year under review proved to be effective. The substantial increase in operational profitability resulted in a margin of more than 20% for the first time.
On 13 September 2016, Swiss Medical Network launched an acquisition offer for all shares of Générale Beaulieu Holding SA. The offered price per share of Générale Beaulieu Holding SA amounted to CHF 25′000. On 31 December 2016, Swiss Medical Network SA held 67.99% of Générale Beaulieu Holding SA. The Société coopérative médicale de Beaulieu, which holds 28.7% of Générale Beaulieu Holding SA, has until the end of 2017 to either sell its shares according to the conditions of the offer, or remain a shareholder alongside Swiss Medical Network. Générale Beaulieu Holding SA has been consolidated into Swiss Medical Network SA as of 1 November 2016.
Clinique Générale-Beaulieu, founded in 1899, is a multidisciplinary private hospital, specialised in orthopaedics, general surgery, urology, gynaecology and obstetrics. The hospital also has a radiology institute, an institute of nuclear medicine and a physiotherapy & functional rehabilitation centre. The hospital buildings, which are now owned by the Group, are ideally located in the heart of the residential area of Champel in Geneva, in very pleasant natural surroundings. The main building of the hospital was constructed in 1983 and has a total surface of 18,000 sqm. On its site and the various annex buildings, Clinique Générale-Beaulieu accommodates approximately 70 medical practices covering all medical specialties.
Clinique Générale-Beaulieu has 477 employees and 571 admitting physicians. With a turnover of CHF 83.4 million, Clinique Générale-Beaulieu is now the second largest hospital of Swiss Medical Network, followed by Clinique de Genolier and Privatklinik Bethanien.
After the integration of Clinique Générale-Beaulieu, the network now consists of 15 hospitals, one affiliated hospital as well as one clinic, with 988 available beds, 1′782 admitting physicians and 2′948 employees. Swiss Medical Network has an outstanding track record in acquiring and restructuring private hospitals. This buy-and-build strategy will be continued in the years to come as the Group matures on its way to reaching the medium-term goal of 20–25 hospitals in the majority of Switzerland′s cantons. The current acquisition pipeline looks promising, and it is expected that Swiss Medical Network will again be engaged in acquisitions to expand its unique network of medical excellence in the months to come.
The number of admitting physicians continued to grow. The underlying attractiveness of the network′s hospitals encouraged 76 new doctors to join the Group. The ability to perform state-of-the-art medicine in well-equipped hospitals applying an entrepreneurial approach, in a pleasant environment, makes the Swiss Medical Network hospitals unique working places. During the past year, the network′s physicians conducted nearly 53′000 interventions and carried out more than 2′500 deliveries. A survey carried-out by ANQ, the Swiss association for quality development in hospitals and clinics, showed very high patient satisfaction in the hospitals of Swiss Medical Network.
1′782 admitting physicians and 2′948 employees
In addition, the establishment of competence centres and the build-up of regional platforms progressed in the reporting period. The aim of the network to continuously enhance the level of specialisation and quality is supported by investments in cutting-edge medical technology and infrastructure, including high-quality hospitality services. At Clinique de Genolier, a new catheterisation room equipped with a new cardiovascular technical platform helps to put the hospital at the top of the field. The creation of the "Gyne Centro Ticino" and the installation of a spectral computer tomography device at the Clinica Sant′Anna (only the second in Switzerland, with the other at Clinique de Genolier) upgraded the hospital′s offering. At Privatklinik Bethanien, the creation of a new neurosurgery practice further strengthened the hospital′s expertise in this growing field.
Lowest base rate of CHF 8′930 per case
By further intensifying the efforts already made during the last years, Swiss Medical Network took another important step in reducing its tariffs. In early March 2016, a common flat rate payment system for all listed hospitals was introduced. As a direct consequence of the increased efficiency of the hospital group in the year under review, the base rates were further reduced by CHF 100 as of 1 January 2017. These base rates are substantially lower than the insurers′ benchmark (HSK and Tarifsuisse, both around CHF 9′500) and around 10% below those of the public hospitals (above CHF 10′000). Swiss Medical Network remains committed to further improving efficiencies and passing on the gains to the insured, while generating profit margins that allow investments in infrastructure and people. The ability of Swiss Medical Network to lower its flat rate is a crucial contribution to containing healthcare costs in Switzerland and underlines the importance of well-managed, cost-conscious private healthcare providers.
The importance of the Group as a key partner is highlighted by the establishment of multi-year term tariff agreements with all major insurance companies for all the hospitals in the network. Swiss Medical Network thereby follows a flexible business model combining contracted hospitals with listed hospitals. In the field of contracted hospitals, insurance coverage for listed specialties can be negotiated while the hospitals remain a health partner for the public authorities. In the field of listed hospitals, a hospital can negotiate insurance coverage for non-listed specialties. Swiss Medical Network advocates for the equal treatment of private and public hospitals. Patients must have a real free choice to select their healthcare provider or physician, and every institution should be eligible to get the basic allowance ("Sockelbeitrag"). On the other hand, volume quotas for services or other limitations (medical materials) will be rejected going forward.
| ADMITTING | ||||
|---|---|---|---|---|
| CANTON | HOSPITAL | EMPLOYEES | PHYSICIANS | AVAILABLE BEDS |
| Contracted hospitals | ||||
| Vaud | Clinique de Genolier | 302 | 137 | 112 |
| Vaud | Clinique de Montchoisi | 99 | 120 | 22 |
| Vaud | Clinique Valmont | 122 | 6 | 59 |
| Zurich | Privatklinik Bethanien | 250 | 257 | 96 |
| Zurich | Privatklinik Lindberg | 200 | 89 | 73 |
| Zurich | Pyramide am See* | 115 | 125 | 40 |
| Listed hospitals | ||||
| Neuchâtel | Clinique Montbrillant | 60 | 97** | 26 |
| Neuchâtel | Hôpital de la Providence | 240 | 97** | 59 |
| Fribourg | Clinique Générale | 150 | 77 | 66 |
| Geneva | Clinique Générale-Beaulieu | 477 | 571 | 131 |
| Valais | Clinique de Valère | 158 | 52 | 46 |
| Solothurn | Privatklinik Obach | 120 | 40 | 54 |
| Aargau | Privatklinik Villa im Park | 90 | 42 | 39 |
| Basel | Schmerzklinik Basel | 70 | 31 | 15 |
| Ticino | Clinica Sant′Anna | 173 | 70 | 80 |
| Ticino | Clinica Ars Medica | 176 | 44 | 70 |
| Clinic | ||||
| Geneva | Centre Médical des Eaux-Vives | 29 | 24 | 0 |
| Total | 2′948*** | 1′782 | 988 |
* affiliated hospital
** All doctors accredited at Hôpital de la Providence are also accredited at Clinique Montbrillant.
*** Including the employees of the Group′s central services
The development of Swiss Medical Network and the further integration of hospitals will continue, as the pipeline looks promising. The recruitement of new physicians is a key priority of Swiss Medical Network. New collaboration platforms and centers of excellence are being built up to promote the sharing of knowledge, resources and technology, in order to optimise the medical outcome for each patient. The focus on cost cutting, the exploitation of synergies and efficiency gains will have a positive effect on profitability. Swiss Medical Network will continue to be active on a federal and cantonal level to promote unbiased competition, for the benefit of the patients and for a more efficient healthcare system. Swiss Medical Network has the ambition to become the preferred partner for public institutions, the insurance sector and all stakeholders of the medical sector in Switzerland.
Raymond Loretan Beat Röthlisberger Executive Chairman CEO
Recruitment of physicians is of key importance
The Victoria-Jungfrau Collection is a small but exclusive hotel group with a unique portfolio of luxury five-star hotels of long standing. The Victoria-Jungfrau Grand Hotel & Spa in Interlaken and the Palace Luzern on the shores of Lake Lucerne were joined as members of the Victoria-Jungfrau Collection by the Eden au Lac in Zurich in November 2005 and the renowned Bellevue Palace in Bern in January 2007. The latest hotel to have joined the Collection is the Crans Ambassador Hotel in Crans-Montana.
All hotels are individually managed but share a commitment to personal hospitality and top-quality service. The historic establishments with Swiss tradition offer luxurious accommodation, gourmet cuisine, wellness and contemporary infrastructure to their guests. The Victoria-Jungfrau Collection yearly counts around 169′000 overnight bookings.
AEVIS VICTORIA owns 100% of the Interlaken based luxury hotel group.
www.vjc.ch
The offerings of the five luxury hotels of Victoria-Jungfrau Collection, the Victoria-Jungfrau Grand Hotel & Spa in Interlaken, the Eden au Lac in Zurich, the Bellevue Palace in Berne and the Palace in Lucerne, as well as the newly integrated Crans Ambassador in Crans-Montana, were in solid demand in 2016. Net revenue of the five hotels (12 months consolidated for three hotels, one month consolidated for the Crans Ambassador, management fees for the Palace in Lucerne) reached CHF 60.7 million, based on a well-diversified customer portfolio that once again proved advantageous in times where travel destinations change quickly. The management fee from the Palace in Lucerne, efficiency gains and cost savings contributed to the profitability, and the EBITDAR margin reached 20.1%.
EBITDAR surges to CHF 12.2 million
The tourism industry in Switzerland was affected by the fear of further terrorist attacks in Europe and the strong Swiss Franc, which remained a challenge. Overall, the number of travellers declined once again. However, the luxury hotels of Victoria-Jungfrau Collection were able to compensate, performing very well in the reporting period. The Bellevue Palace in Berne in particular displayed solid turnover growth, while the luxury hotels of the Group located in Interlaken and Zurich posted turnover in line with the previous year′s figures. Overall, a highlight of the 2016 results was the net revenue growth from CHF 58.9 million in 2015 to CHF 60.7 million this year. The Palace Lucerne is operated by the Group but no longer consolidated since a new management contract structure was put in place on 1 January 2016. The number of overnight stays remained constant at around 169′000 and the average room rate increased from CHF 366 a year ago to CHF 372 in the period under review (three fully consolidated hotels).
Productivity further increased in 2016. In addition to increased turnover and the management fee earned from operations at the Palace in Lucerne, efficiency gains and the exploitation of synergies within the Group contributed an EBITDAR of CHF 12.2 million, corresponding to an EBITDAR margin of 20.1%. Further improvements are anticipated in the current business year as energy costs, which represent a sizable part of the cost structure of a hotel, will be reduced based on a Group-wide electricity procurement scheme.
Substantial increase in guests from the United States, the UAE, France and Hong Kong
The management team has further intensified its national and international sales activities in order to respond to the challenging market environment. Although Victoria-Jungfrau Collection profits from a very well-diversified client base, continued efforts are necessary to counteract the difficult market circumstances. This strategy paid off in the period under review. The effects of a 19% decrease in Chinese guests, mainly triggered by new visa regulations, and fewer travellers from Russia and Great Britain, were offset by a substantial increase in guests coming from the United States, the United Arab Emirates, France and Hong Kong. Switzerland remained the biggest market, accounting for approximately 25% of turnover.
The Palace Hotel in Lucerne, bought by Chinese investor Yunfeng Gao in 2015, remains managed by Victoria-Jungfrau Collection. The collaboration was successful in the reporting period, as highlighted by higher occupancy and surging operational profitability.
Refurbishment projects bolster market position
Unique customer experiences and outstanding services are key to defending the solid market position achieved. Therefore, investments in refurbishment projects and the expansion of services are regularly implemented. At the Victoria-Jungfrau Grand Hotel & Spa in Interlaken, the flagship hotel of the group, the renovated restaurant "La Terrasse" was reopened in the spring, and "The Garden" is a new attraction during the summer months. In October 2016, the hotel inaugurated its new SPA Nescens, a comprehensive spa offering a unique range of services and better-aging programs, in an elegant, lush green setting. The refurbishment, including the installation of air conditioning in 30 rooms, has started, and as of next summer, an enhanced experience, especially during the summer, will be ensured. At the Bellevue Palace in Berne, a major renovation project has been completed and all rooms now offer state-of-the-art amenities. It is foreseen that the Eden au Lac in Zurich will undergo a major renovation phase in the years to come, in order to provide a facelift to the existing facilities and turn the establishment into an outstanding reference for city hotels. The intended project is currently in the approval process and clearance is expected later this year.
On 1 December 2016, the Group acquired the operations of the Hotel Crans Ambassador, a luxury sport resort in Crans-Montana (canton of Valais). The hotel is ideally located in the prestigious ski resort of Crans-Montana, offering a panoramic view of the Swiss Alps. The Group does not own the hotel premises but signed a long-term lease with the owner. Results have been consolidated for the month of December 2016.
| TOTAL | SURFACE | ||||
|---|---|---|---|---|---|
| ROOMS | SUITES | (sqm) | EMPLOYEES | ||
| Victoria-Jungfrau Grand Hotel and Spa | 224 | 102 | 44′269 | 227 | |
| Eden au Lac | 50 | 5 | 1′419 | 54 | |
| Palace Luzern | 129 | 31 | 3′337 | 106 | |
| Bellevue Palace | 128 | 25 | 3′296 | 128 | |
| Crans Ambassador | 56 | 12 | 10′898 | 60 |
The Victoria-Jungfrau Collection product is attractive and in demand across a wide range of customers. Even though the Swiss tourism industry faces major challenges, the Group′s hotels are expected to match the performance achieved in 2016. The diversified customer base, regular investments in the infrastructure and services and the exploitation of additional synergistic potential will remain the keys to success.
| Christian Seiler | Beat Sigg |
|---|---|
| Chairman | CEO |
Regular investments into refurbishment projects and the expansion of services
Swiss Healthcare Properties AG (SHP I), founded in 1997, is a unique healthcare-related real estate company in Switzerland. The portfolio of SHP I, with a market value of CHF 779.4 million and a rental surface of 133′318 sqm consists of 33 quality entities situated in premium locations. All properties are fully let, mainly to the various Swiss Medical Network hospitals, and have been bought or constructed in the context of the development of the group. SHP I′s properties present a development potential of 35′000 sqm. SHP I has a buy/build & hold strategy with a long-term perspective of ongoing renovation and maintenance programs.
The real estate company is committed over the long-term to the hospital′s operations growth but also aims to realise healthcare-related real estate acquisitions with reliable operators outside the Swiss Medical Network. SHP I is a 100% subsidiary of AEVIS VICTORIA.
Générale-Beaulieu Immobilière SA owns the hospital premises of Clinique-Générale-Beaulieu as well as several other buildings surrounding the hospital. The three properties represent a rental surface of 18′990 sqm and a market value of CHF 190.8 million.
Swiss Hospitality Properties in Interlaken AG (SHP II) owns the buildings of the hotels Eden au Lac in Zurich and Victoria-Jungfrau Grand Hotel & Spa in Interlaken, as well as six smaller annex properties in Interlaken. The 8 properties represent a rental surface of 41′572 sqm and a market value of CHF 163.3 million. SHP II is a 100% subsidiary of AEVIS VICTORIA.
www.shp.net
The real estate segment continued its expansion in the year under review. With the acquisition of an office building in Echandens and the integration of three buildings in Geneva in connection with the acquisition of Générale Beaulieu Holding, the healthcare- and hotel-related real estate portfolio grew to 44 properties on 17 sites. Rental income amounted to CHF 51.2 million (2015: CHF 36.4 million) and EBITDAR surged to CHF 42.4 million (2015: CHF 32.5 million), which mostly corresponds to intercompany payments with AEVIS VICTORIA′s hospital and hotel segments. The portfolio represents a total rentable surface of 193′880 sqm with a market value of CHF 1′148.3 million. The loan to value remains very low at 35.2%. The average interest on mortgages was 1.72% at the end of 2016.
The real estate segment of AEVIS VICTORIA is composed of healthcare- and hospitality-related real estate and is subdivided into Swiss Healthcare Properties SA (SHP l), Swiss Hospitality Properties SA (SHP ll) and Générale-Beaulieu Immobilière SA. SHP I owns most of the hospital buildings of Swiss Medical Network and some outbuildings next to the hospitals, used as doctors′ offices and for administration, while SHP II owns the hotel premises of Victoria-Jungfrau Collection in Zurich and Interlaken. Générale-Beaulieu Immobilière SA owns the hospital premises of Clinique Générale-Beaulieu as well as several other buildings surrounding the hospital.
| NAME | MAIN USE | PLACE (CANTON / NUMBER OF BUILDINGS) |
RENTAL AREA (sqm) |
PARKING SPACES |
|---|---|---|---|---|
| Clinique de Genolier | Multi-specialty hospital | Genolier (VD / 4) | 32′903.7 | 388 |
| Clinique de Montchoisi | Multi-specialty hospital | Lausanne (VD) | 3′441.0 | 43 |
| Clinique Valmont | Rehabilitation hospital | Glion-sur-Montreux (VD) | 6′733.0 | 22 |
| Clinique Générale | Multi-specialty hospital | Fribourg (FR) | 6′540.1 | |
| Clinica Ars Medica | Multi-specialty hospital | Gravesano (TI) | 8′075.0 | 123 |
| Clinica Sant′Anna | Multi-specialty hospital | Sorengo (TI / 6) | 14′508.7 | 188 |
| Privatklinik Lindberg | Multi-specialty hospital | Winterthur (ZH / 4) | 13′078.6 | 117 |
| Privatklinik Obach | Multi-specialty hospital | Solothurn (SO / 2) | 5′838.9 | 92 |
| Clinique de Valère | Multi-specialty hospital | Sion (VS / 2) | 9′565.0 | 110 |
| Privatklinik Bethanien | Multi-specialty hospital | Zürich (ZH / 5) | 18′546.0 | 210 |
| Klinik Villa im Park | Multi-specialty hospital | Rothrist (AG / 2) | 4′320.0 | 77 |
| Hangar SHP (Air-Glaciers) | Hangar (air rescue) | Sion (VS) | 2′284.9 | 14 |
| Clinique Montbrillant | Multi-specialty hospital | La Chaux-de-Fonds (NE / 2) | 5′715.0 | 59 |
| Chocolatière 21 | Offices | Echandens (VD) | 1′768.0 | 53 |
| Clinique Générale-Beaulieu | Multi-specialty hospital | Genève (GE / 3) | 18′990.0 | 310 |
| Hotel Victoria-Jungfrau | Hotel | Interlaken (BE / 7) | 37′120.0 | 170 |
| Hotel Eden au Lac | Hotel | Zürich (ZH / 1 ) | 4′452.0 | 18 |
SHP I is composed of 33 quality entities on 14 sites with a rental surface of 133′318 sqm, a market value of CHF 779.4 million and additional development potential of up to 35′000 sqm. The portfolio was enlarged by one entity in the period under review with the integration of an office building in Echandens, located between Morges and Lausanne. The building is on a plot area of 2′881 sqm and offers rental space of 1′768 sqm with 53 parking spaces. The building is in very good condition and is fully let. Swiss Medical Network occupies the first floor, thus bundling all major administration-related works in one location.
Générale-Beaulieu Holding, operating a hospital in Geneva, was acquired in the second half of 2016 by Swiss Medical Network. The transaction included the purchase of three buildings on the hospital site in a residential area of Geneva. The properties offer 18′990 sqm rental space and had a market value of CHF 190.8 million at the end of 2016.
SHP II consists of seven properties in Interlaken (the Victoria-Jungfrau Grand Hotel & Spa and six smaller annex buildings) and the Eden au Lac building in Zurich, representing a total rental surface of 41′572 sqm and a market value of CHF 163.3 million. The old unoccupied building "Schweizerhof" in Interlaken has been demolished. The open space will be landscaped and the shopping area in proximity to the Victoria-Jungfrau Grand Hotel & Spa will be upgraded.
An extensive refurbishment program was completed at Clinique de Valère in Sion. The standard for the patient rooms was improved, and new suites and hospitality areas were created. This major renovation will enable the hospital to further advance its activities in the years to come. Targeted investments have also been made in Clinique Générale in Fribourg, Clinique Montchoisi in Lausanne, Clinica Ars Medica in Gravesano, Privatklinik Lindberg in Winterthur and Privatklinik Bethanien in Zurich. All these investments contribute to a state-of-the-art patient experience and underpin the unique positioning of the hospitals of Swiss Medical Network. To save energy and reduce energy costs, the central heating regulation systems have been upgraded in Clinique de Genolier, Clinica Ars Medica and Clinica Sant′Anna.
The construction of a new building in Rothrist for the Privatklinik Villa im Park will start in April 2017. The additional building will offer rental space of 2′300 sqm and contain 30 new rooms offering a maximum of 56 beds, 4 operating theatres and an underground parking with more than 100 places. Construction is expected to last until late 2018.
The evolution of the hospital′s activities creates a need for additional surfaces on many sites. In order to meet the expected future demand from the hospitals, plans are being developed to increase the ground area ratio either by changing area plans or by searching for new buildings near the current premises. In Zurich, adjacent to Privatklinik Bethanien, SHP I owns a plot of 4′623 sqm with three buildings. It is planned to replace the old buildings with a new one of around 6′000 sqm to be used by Privatklink Bethanien. Furthermore, SHP I continued to work on the development of a large project in Genolier (additional 15′000 sqm on the existing plot) and expansion of the hospital in Gravesano (new land use plan in discussion), both of them depending on communal or cantonal approvals. The city of Winterthur and the canton of Zurich have approved the plans submitted by Privatklinik Lindberg to construct an additional 11′000 sqm on the plot.
Antoine Hubert Christoph Syz Chairman CEO
Investments into environment-friendly technologies
AEVIS VICTORIA invests in various other activities along the value chain of its main divisions
AEVIS VICTORIA SA invests in various other activities along the value chain of its main divisions. Although these ventures account for a small portion of total revenues, they reflect the Group′s vision of becoming an integrated healthcare provider. In January 2016, AEVIS VICTORIA acquired a participation of 40% in Medgate Group, the leading provider of integrated out-patient healthcare in Switzerland. Furthermore, AEVIS VICTORIA and its reference shareholders acquired 11.99% of the listed company LifeWatch AG, a leading developer and provider of remote diagnostic monitoring services in the digital health market.
Medgate is one of the leading providers of integrated outpatient healthcare in Switzerland and employs around 100 physicians. The Medgate Telemedicine Center in Basel (in operation since 2000), Medgate Health Centres and the Medgate Partner Network work together closely. This network of telemedicine and medical centres, as well as external specialists and basic healthcare providers, guarantees comprehensive, efficient and high-quality care for patients. The Medgate Telemedicine Center is delivering up to 5′000 teleconsultations a day. Medgate internationalised its successful business model and offers its different telemedicine services in Abu Dhabi, in Australia and, since 2016, in the Philippines. AEVIS VICTORIA holds a 40% stake in the Medgate Group, while its founders, Andy Fischer and Lorenz Fitzi, remain the majority shareholders. Medgate continued to expand during the reporting period. In addition to the third international outlet, business Switzerland was bolstered once again. The partnership with the Federal Office of Health in the field of vaccination was renewed after 10 years, and the Medgate Telemedicine Centre will continue to operate the vaccine hotline for the next five years after winning a public tender. In general, demand for telemedical consultations is expected to increase significantly, both in Switzerland and abroad. On the medical side, this growth is driven by the pressure on healthcare costs and progress in the use of telemedicine sensors. On the technological side, it is driven by the increased availability of powerful transmission technologies.
To lever and link selected points of excellence within both the hospital and hotel segments, AEVIS VICTORIA has developed the umbrella brand Nescens focused on products and services aimed at helping people to live and age better. Nescens is built on five pillars: Nescens Check-up Centres (linked with selected hospitals of Swiss Medical Network), Nescens better-aging therapies (linked with Victoria-Jungfrau Collection as well as La Reserve Hotel & Spa), Nescens aesthetic surgery and medicine (Clinique Nescens – Paris Spontini), Nescens cosmeceuticals (Laboratoires Genolier) and Nescens Swiss Stem Cell Science.
With Swiss Ambulance Rescue, AEVIS VICTORIA intends to contribute to a potential consolidation of the Swiss rescue sector, which is highly fragmented. AEVIS VICTORIA SA holds a 93.4% stake in Swiss Ambulance Rescue Genève SA, which is a leading private ambulance operator in Geneva. The company is specialised in repatriations, urgent patient transport and hospital transfers in the Geneva area. The company operates 11 vehicles and employs 66 people.
Since 1993, LifeWatch has provided healthcare providers with comprehensive remote cardiac monitoring diagnostic services, allowing timely access to patient arrhythmia data and facilitating better collaboration on and earlier intervention in health events.
The company is listed on the international standard of SIX Swiss Exchange (LIFE, security no. 1′281′545). AEVIS VICTORIA and its reference shareholders hold an 11.99% participation in the company that was built up in the course of 2016. LifeWatch achieved a turnover of USD 113.8 million, an operating loss of USD 7.7 million and a net loss of USD 13.4 million in the financial year 2016.
On 24 January 2017, AEVIS VICTORIA launched a public takeover offer for all publicly held shares of LifeWatch AG, and on 20 February 2017 the corresponding prospectus was published. LifeWatch shareholders can opt for an exchange offer or a cash alternative. For each registered share of LifeWatch, AEVIS VICTORIA offers 0.1818 registered shares of AEVIS VICTORIA with a nominal value of CHF 5.00. Alternatively, AEVIS VICTORIA offers CHF 10.00 in cash per registered share of LifeWatch. The offer period will start on 7 March 2017 and end on 10 April 2017 at 16.00 CEST.
The public takeover offer is subject to several conditions, one of which being that AEVIS VICTORIA holds 67% of the LifeWatch registered shares at the end of the offer period. Upon successful completion of the offer, LifeWatch would become an independently managed subsidiary of AEVIS VICTORIA, allowing AEVIS VICTORIA to sustainably reinforce its telemedicine activities.
AEVIS VICTORIA intends to significantly contribute to pursuing LifeWatch′s growth strategy and is convinced that LifeWatch would benefit from the support of a reference shareholder with a strong presence in the healthcare sector. AEVIS VICTORIA would be able to provide a long-term vision and the necessary financial means to develop the business model. AEVIS VICTORIA has a proven track record in transforming and growing companies in the health sector, and LifeWatch would also benefit from this broad experience.
On 9 March 2017, a committee of the Board of Directors of LifeWatch has recommended the rejection of AEVIS VICTORIA′s offer. The committee considers AEVIS VICTORIA′s offer not to be in the best interest of LifeWatch and its shareholders as they believe that it does not reflect the real value of the company. The committee has solicited alternative offers and mandated an investment bank to help them in this process. AEVIS VICTORIA is concerned about how the process is being handled by the committee and management of LifeWatch. AEVIS VICTORIA will wait and see how the transaction evolves and the take the necessary measures in due course to protect the best interest of its shareholders.
The AEVIS VICTORIA Group (hereinafter "the Group") is active in services to people, healthcare, hospitality, life sciences and lifestyle. The Group′s operational structure is divided into the following main business segments: hospitals, hospitality, telemedicine and real estate. The other smaller subsidiaries are active in life sciences (better aging) and in ambulance services. Each business segment is managed by an Executive Committee or Management Team, reporting to their respective Board of Directors.
| NAME | REGISTERED OFFICE |
ACTIVITY | SHARE CAPITAL IN CHF |
% |
|---|---|---|---|---|
| Swiss Medical Network SA | Genolier (VD) | Holding company of private hospitals |
100′000 | 100.0 |
| Victoria-Jungfrau Collection AG | Interlaken (BE) | Holding company of hotels | 200′000 | 100.0 |
| Swiss Healthcare Properties SA | Fribourg (FR) | Medical real estate | 10′000′000 | 100.0 |
| Swiss Hospitality Properties AG | Interlaken (BE) | Hospitality real estate | 200′000 | 100.0 |
| Patrimonium Healthcare Property Advisors AG |
Baar (ZG) | Real estate management | 100′000 | 50.0 |
| Swiss Ambulance Rescue Genève SA | Geneva (GE) | Ambulance services | 500′000 | 93.4 |
| Medgate Integrated Care Holding AG | Zug (ZG) | Holding company in telemedicine |
2′001′700 | 40.0 |
| Medgate Holding AG | Zug (ZG) | Holding company in telemedicine |
200′000 | 40.0 |
| NESCENS SA | Genolier (VD) | Better aging | 300′000 | 36.17 |
| Laboratoires Genolier SA | Genolier (VD) | Cosmeceutical | 866′700 | 84.0 |
| Swiss Stem Cell Science SA | Fribourg (FR) | Stem Cells | 100′000 | 70.0 |
| Société Clinique Spontini SAS | Paris (France) | Aesthetic hospital in Paris (France) |
2′000′000 EUR |
100.0 |
| Publications de l′économie et de la finance AEF SA |
Lausanne (VD) | Publishing | 665′000 | 49.0 |
| Agefi Com SA | Geneva (GE) | Publishing (dormant) | 200′000 | 49.0 |
| Academy & Finances SA | Geneva (GE) | Organisation of seminars | 250′000 | 22.5 |
| Publications Financières LSI SA | Geneva (GE) | Publishing (dormant) | 100′000 | 100.0 |
According to the information received by the Company, the shareholders holding directly or indirectly 3% or more of the share capital are:
| NAME | 31.12.2016 NUMBER OF SHARES |
31.12.2016 % |
31.12.2015 NUMBER OF SHARES |
31.12.2015 % |
|---|---|---|---|---|
| Group Hubert/Reybier/M.R.S.I. Medical Research, Services and Investments SA* |
11′726′172 | 77.49 | 11′634′382 | 77.38 |
| Kuwait Investment Office as agent for the Government of the State of Kuwait |
533′312 | 3.52 | 533′312 | 3.55 |
* Antoine Hubert and Géraldine Reynard-Hubert hold indirectly AEVIS VICTORIA shares through M.R.S.I. Medical Research, Services and Investments SA and HR Finance & Participations SA (HRFP). Antoine Hubert and Géraldine Reynard-Hubert hold 100% of the share capital and voting rights of HRFP. HRFP holds 50% of the share capital and voting rights of MRSI. Michel Reybier holds indirectly AEVIS VICTORIA shares through M.R.S.I. Medical Research, Services and Investments S.A. and EMER Holding SA (EMER). Michel Reybier holds 100% of the share capital and voting rights of EMER. EMER holds 50% of the share capital and voting rights of MRSI.
| AUDIT AND COMPLIANCE COMMITTEE |
NOMINATION AND COM PENSATION COMMITTEE |
STRATEGY AND INVESTMENT COMMITTEE |
|
|---|---|---|---|
| Christian Wenger | Member | Member | |
| Raymond Loretan | Member | ||
| Antoine Hubert | Member | ||
| Michel Reybier | Member | Chairman | |
| Antoine Kohler | Chairman | Member | |
| Cédric A. George | Chairman | Member | |
| Dr Philippe Glasson* | Member |
* Vice-chairman of the Board of Directors of Swiss Medical Network SA
All shareholders recorded in the share register with voting rights are entitled to attend and vote at the Annual General Meetings. Each share recorded in the share register with a right to vote entitles the holder to one vote at Annual General Meetings. In accordance with article 16 of the Articles of Association, any shareholder recorded in the share register may be represented at the Annual General Meeting by the independent proxy, another shareholder or a third party. Shareholders have the option to receive their documents for the Annual General Meeting or issue proxies and instructions to the independent proxy electronically via the Sherpany online platform.
The invitation to the meeting must indicate the items on the agenda and the motions of the Board of Directors and of those shareholders who have requested that the meeting be convened or that an item be included in the agenda. In compliance with article 699 paragraph 3 Swiss Code of Obligations, shareholders representing shares amounting to a nominal value of CHF 1 million may submit a written request for an item to be included in the agenda.
The Company does not have a provision on opting out or opting up in the Articles of Association. Thus, according to article 9 of the Articles of Association, the provisions regarding the legally prescribed threshold of 33 1/3% of the voting rights for making a public takeover set out in article 32 of the Stock Exchange Act are applicable.
Berney & Associés SA Société Fiduciaire, Geneva was first appointed on 09.06.2010 as auditor of the Company and of the Consolidated Financial Statements of the Group.
| NAME | POSITION | TOTAL | OF WHICH CASH (in 1′000 CHF) |
OF WHICH BLOCKED SHARES |
PREVIOUS PERIOD |
|---|---|---|---|---|---|
| Christian Wenger | Chairman | 100.0 | 75.0 | 25.0 | 100.0 |
| Raymond Loretan | Vice-chairman | – | – | – | – |
| Antoine Hubert | Delegate of the Board | – | – | – | – |
| Cédric A. George | Member | 68.0 | 54.4 | 13.6 | 68.0 |
| Antoine Kohler | Member | 93.0 | 46.5 | 46.5 | 93.0 |
| Michel Reybier | Member | 50.0 | 25.0 | 25.0 | 50.0 |
These are net amounts. Social insurance and pension contributions are paid by the company. Antoine Hubert and Raymond Loretan are employed by a Group′s subsidiary and do not receive any Board Member compensation.
The total remuneration of the Senior Management (including social insurance and pension contributions) amounts to CHF 1.4 million (2015: CHF 0.50 million). Stock options were granted in 2016 (2015: n.a.). The highest compensation in 2016 was conferred to Antoine Hubert, Delegate of the Board.
| Total | 1′379.8 | 29.8 | 1′409.6 | 504 | – | 504 |
|---|---|---|---|---|---|---|
| Pension Scheme Contribution | 112.9 | – | 112.9 | 108 | – | 108 |
| Stock options* | 447.0 | 29.8 | 476.8 | – | – | – |
| Variable cash compensation | 422.7 | – | 422.7 | – | – | – |
| Annual Base Salary | 397.2 | – | 397.2 | 396 | – | 396 |
| In thousands of CHF | 2016 HIGHEST COMPENSA TION |
2016 OTHER MEMBERS |
2016 TOTAL SENIOR MANAGE MENT |
2015 HIGHEST COMPENSA TION |
2015 OTHER MEMBERS |
2015 TOTAL SEN IOR MAN AGEMENT |
* Black-Scholes model
| (In thousands of CHF) | NOTES | 2016 | 2015 RESTATED |
|---|---|---|---|
| Revenue from operations | 584′453 | 564′938 | |
| Other revenue | 8′142 | 11′120 | |
| Total revenue | 592′595 | 576′058 | |
| External services | (75′489) | (67′451) | |
| Net revenue | 517′106 | 508′607 | |
| Production expenses | (115′383) | (112′514) | |
| Personnel expenses | 5 | (236′985) | (236′996) |
| Other operating expenses | 6 | (77′597) | (80′645) |
| EBITDAR (Earnings before interest, taxes, depreciation, amortisation and rental expenses) |
87′141 | 78′452 | |
| Rental expenses | (12′536) | (13′939) | |
| EBITDA | 74′605 | 64′513 | |
| Depreciation on tangible assets | 14 | (38′110) | (36′514) |
| Amortisation on intangible assets | 15 | (5′047) | (4′137) |
| EBIT | 31′448 | 23′862 | |
| Financial result | 7 | (24′969) | (22′949) |
| Share of profit/(loss) of associates | (1′784) | (107) | |
| Ordinary result | 4′695 | 806 | |
| Extraordinary result | 8 | (96) | (326) |
| Profit before taxes | 4′599 | 480 | |
| Income taxes | 9 | (1′907) | 3′267 |
| Profit for the period | 2′692 | 3′747 | |
| – Thereof attributable to shareholders of AEVIS VICTORIA SA | 10 | 2′309 | 3′770 |
| – Thereof attributable to minority interests | 383 | (23) |
| (In thousands of CHF) | NOTES | 31.12.2016 | 31.12.2015 |
|---|---|---|---|
| Assets | |||
| Cash and cash equivalents | 15′207 | 13′068 | |
| Marketable securities | 9′829 | – | |
| Trade receivables | 11 | 113′381 | 113′150 |
| Other receivables | 12 | 40′147 | 49′848 |
| Inventories | 13 | 19′201 | 17′514 |
| Accrued income and prepaid expenses | 35′108 | 23′308 | |
| Total current assets | 232′873 | 216′888 | |
| Fixed assets | 14 | 1′377′935 | 1′126′161 |
| Intangible assets | 15 | 40′249 | 25′491 |
| Financial assets | 16 | 68′704 | 17′518 |
| Total non-current assets | 1′486′888 | 1′169′170 | |
| Total assets | 1′719′761 | 1′386′058 | |
| Liabilities and equity | |||
| Trade payables | 17 | 92′371 | 88′972 |
| Other current liabilities | 18 | 19′398 | 20′243 |
| Short-term financial liabilities | 19 | 23′172 | 100′197 |
| Other short-term borrowings | 800 | 800 | |
| Accrued expenses and deferred income | 20 | 43′662 | 47′181 |
| Short-term provisions | 21 | 282 | 482 |
| Total current liabilities | 179′685 | 257′875 | |
| Long-term financial liabilities | 19 | 993′125 | 703′621 |
| Other long-term borrowings | 16′270 | 16′755 | |
| Other non-current liabilities | 18 | 13′919 | 14′412 |
| Long-term provisions | 21 | 135′262 | 92′844 |
| Total non-current liabilities | 1′158′576 | 827′632 | |
| Total liabilities | 1′338′261 | 1′085′507 | |
| Equity | |||
| Share capital | 22 | 75′662 | 75′176 |
| Capital reserves | 245′945 | 251′075 | |
| Treasury shares | 22.1 | (5′630) | (1′075) |
| Offset goodwill | (30′370) | (47′480) | |
| Currency translation differences | (1′077) | (990) | |
| Retained earnings | 26′198 | 24′021 | |
| Shareholders′ equity excl. minority interests | 310′728 | 300′727 | |
| Minority interests | 70′772 | (176) | |
| Shareholders′ equity incl. minority interests | 381′500 | 300′551 | |
| Total liabilities and equity | 1′719′761 | 1′386′058 |
| (In thousands of CHF) | 2016 | 2015 RESTATED |
|---|---|---|
| Profit for the period | 2′692 | 3′747 |
| Changes in provisions (incl. deferred taxes) | (1′483) | (10′139) |
| Depreciation and amortisation | 43′157 | 40′651 |
| (Gain)/loss from sale of fixed assets | 13 | (514) |
| (Gain)/loss from sale of subsidiaries | (4) | – |
| Fair value (gains)/losses on marketable securities | (17) | – |
| Share of (profit)/loss from associates | 1′793 | 107 |
| Dividends received from associates | 244 | – |
| Share-based payments | 548 | 346 |
| Change in contribution reserve and other non-cash items | 23 | 3′115 |
| Cash flow from operating activities before changes in working capital | 46′966 | 37′313 |
| Change in trade receivables | 13′112 | (10′850) |
| Change in inventories | 1′358 | (215) |
| Change in other receivables and prepaid expenses | (4′346) | (9′037) |
| Change in trade payables | (98) | 13′069 |
| Change in other liabilities and accrued expenses | (1′392) | 6′295 |
| Cash flow from operating activities | 55′600 | 36′575 |
| Purchase of fixed assets | (45′925) | (124′389) |
| Proceeds from disposal of fixed assets | 427 | 28′461 |
| Purchase of intangible assets | (8′419) | (6′302) |
| Acquisition of subsidiaries, net of cash acquired | (126′525) | (17′820) |
| Divestment of subsidiaries, net of cash disposed | 3 | – |
| Investments in financial assets and marketable securities | (47′277) | 7′468 |
| Divestments of financial assets and marketable securities | 2′934 | – |
| Cash flow from investing activities | (224′782) | (112′582) |
| Distribution to shareholders | (8′103) | (7′670) |
| Proceeds from issuance of share capital, net of costs | 2′722 | – |
| Proceeds from issuance of bond | 295′000 | – |
| Repayment of bond | (80′000) | – |
| Sale/(purchase) of treasury shares | (11′365) | (912) |
| Change in minority interests | (64) | (10′308) |
| Change in short-term financial liabilities | 1′915 | 1′030 |
| Change in long-term financial liabilities | (28′888) | 60′609 |
| Change in other long-term liabilities and borrowings | 109 | (2′172) |
| Cash flow from financing activities | 171′326 | 40′577 |
| Currency translation effect on cash and cash equivalents | (5) | (76) |
| Change in cash and cash equivalents | 2′139 | (35′506) |
| Cash and cash equivalents at beginning of the period | 13′068 | 48′574 |
| Cash and cash equivalents at the end of the period | 15′207 | 13′068 |
| 2016 | HOSPITA | REAL | CORPO | ELIMINA | |||
|---|---|---|---|---|---|---|---|
| (In thousands of CHF) | HOSPITALS | LITY | ESTATE | OTHERS | RATE | TIONS | TOTAL |
| Net revenue 3rd | 443′187 | 59′888 | 3′525 | 10′483 | 23 | – | 517′106 |
| Net revenue IC | 3′046 | 782 | 47′705 | 285 | 1′093 | (52′911) | – |
| Net revenue | 446′233 | 60′670 | 51′230 | 10′768 | 1′116 | (52′911) | 517′106 |
| Production expenses | (105′038) | (8′774) | – | (1′673) | – | 102 | (115′383) |
| Personnel expenses | (190′004) | (30′320) | (351) | (10′186) | (6′124) | – | (236′985) |
| Other operating expenses | (59′243) | (9′380) | (8′454) | (3′002) | (2′621) | 5′103 | (77′597) |
| EBITDAR* | 91′948 | 12′196 | 42′425 | (4′093) | (7′629) | (47′706) | 87′141 |
| EBITDAR margin | 20.6% | 20.1% | 82.8% | – | – | – | 16.9% |
| 2015 (Restated) | HOSPITA | REAL | CORPO | ELIMINA | |||
|---|---|---|---|---|---|---|---|
| (In thousands of CHF) | HOSPITALS | LITY | ESTATE | OTHERS | RATE | TIONS | TOTAL |
| Net revenue 3rd | 416′116 | 76′686 | 2′933 | 12′872 | – | – | 508′607 |
| Net revenue IC | – | 342 | 33′477 | 237 | 157 | (34′213) | – |
| Net revenue | 416′116 | 77′028 | 36′410 | 13′109 | 157 | (34′213) | 508′607 |
| Production expenses | (99′621) | (11′152) | (88) | (1′808) | – | 155 | (112′514) |
| Personnel expenses | (185′831) | (37′459) | (323) | (10′671) | (2′712) | – | (236′996) |
| Other operating expenses | (59′808) | (12′495) | (3′546) | (3′945) | (1′432) | 581 | (80′645) |
| EBITDAR* | 70′856 | 15′922 | 32′453 | (3′315) | (3′987) | (33′477) | 78′452 |
| EBITDAR margin | 17.0% | 20.7% | 89.1% | – | – | – | 15.4% |
* Earnings before interest, taxes, depreciation, amortisation and rent
www.aevis.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.